Revolution of Drug Eluting Coronary Stents: An Analysis of Market Leader

• Main Authors: Ashok S. Thakkar, Bhargav A. Dave
• Format: Article
• Language: English
• Published: European Medical Journal 2016-12-01
• Series: European Medical Journal
• Subjects: biodegradable; bioresorbable vascular scaffold; coronary artery disease (cad); drug-eluting stents (des); percutaneous coronary intervention; polymer; strut; stent coating
• Online Access: https://emj.emg-health.com/wp-content/uploads/sites/2/2016/12/Revolution-of-Drug-Eluting-Coronary-Stents-An-Analysis-of-Market-Leader.pdf

Percutaneous coronary intervention with drug-eluting stents (DES) is a well-established and widelyaccepted treatment approach in patients with coronary artery disease. Although the underlying principle of DES remains constant for different stents available on the market, certain factors may offer variations with respect to deliverability (ease of placement), efficacy (preventing restenosis), and safety (thrombosis rates). These factors may include the type of drug (sirolimus, everolimus, biolimus, zotarolimus, novolimus, paclitaxel, docetaxel), type of stent platforms (stainless steel, platinum, cobalt-chromium, cobalt-nickel, platinum-chromium), type of polymers (permanent, biodegradable, polymer-free), thickness of stent struts (thick, thin, ultra-thin), type of coating (abluminal, conformal), and type of stent design (open-cell, closed-cell, combination of open-closed cell). In this context, we present a review on characteristic features of several of the most widely used coronary stents worldwide. Furthermore, the advancements of completely biodegradable stents are discussed. In addition, the future directions for the development of creating an ideal or perfect DES are debated